Findings from a new randomised controlled trial.

Results from analysis of a nationwide cohort from the United Kingdom.

Donor FMT yields 5-fold better odds of remission than autologous FMT.

Tenofovir may confer better protection than entecavir.

Patients on ipilimumab should be advised to contact their healthcare professional immediately at the onset of symptoms of colitis.

Children more likely to receive immunosuppressants and biologics, but not surgery.

Korean study shows no effect for other HBV-related variables.

A surrogate marker for extent of improvement at 1 year.

Similar outcomes despite larger NAFLD-HCC tumor size.

The study could be the first one to establish a link between diet and behaviour.

No prognostic value found for mesh usage, BMI, age, or other demographic factors.

16-study meta-analysis evaluates the options.

Anxiety more than triples the risk for a poor outcome in this prospective cohort.

Phase 3b trial or patients with bridging fibrosis or compensated cirrhosis.